Beyond the pilot: what determines clinical AI adoption at scale
Why the majority of pathology AI deployments stall between validation and routine use — and what changes the trajectory.
Vendor-neutral strategic advisoryIndependent
Independent
Healthcare AI Advisory
Previsum AI provides independent, vendor-neutral strategic advisory services for healthcare providers, pathology laboratories, diagnostics companies, AI vendors, investors and pharma/biotech organizations. We help leadership teams navigate healthcare AI transformation, digital pathology strategy and technology investment decisions with clinical rigor, commercial clarity and no conflicting interests.
Discuss your AI strategyIndependent · Vendor-neutral · Healthcare-native
The AI transformation challenge
The gap between AI promise and clinical reality
Healthcare leaders are asked to evaluate an accelerating flood of AI technologies — scanners, foundation models, clinical LLMs, platforms, LIS connectors — under real regulatory, clinical and commercial constraints. Most of these decisions are still made without truly independent expertise in the room.
Previsum AI provides the neutral clinical, technical and commercial perspective required to move an AI program from proof-of-concept to standard of care — and to invest in this category with conviction.
4
Audiences served: providers, vendors, investors, pharma
100%
Independent of AI vendors, scanner OEMs and LIS/IMS providers
"The role AI will play in healthcare will require the same independent expert advisory as legal and financial matters."
The Previsum advantage
Built for high-stakes healthcare decisions
01
Healthcare expertise
Deep experience across university hospitals, pathology laboratories, diagnostics and health systems.
02
Digital pathology depth
First-hand knowledge of scanner, IMS and LIS ecosystems and the realities of clinical adoption.
03
AI technology fluency
Rigorous evaluation of foundation models, computer vision and clinical LLM deployments.
04
Independent advisory
Vendor-neutral. Our only interest is the clarity of your decision and the outcome of your program.
Services
All services →Advisory across the AI lifecycle
Healthcare AI Strategy
Defining AI adoption strategy, roadmap and business case.
Digital Pathology Advisory
Supporting pathology and diagnostics transformation end-to-end.
AI Solution Assessment
Independent evaluation of AI technologies and vendor claims.
Vendor & Market Advisory
Helping technology companies succeed in healthcare markets.
Training & Education
AI education for clinicians, executives and technology teams.
Who we advise
Trusted across the healthcare AI ecosystem
Healthcare Providers
University hospitals, pathology labs, diagnostic centers and health systems shaping their AI roadmap.
AI & Digital Pathology Vendors
Startups and large technology companies bringing CE/FDA-stage AI to healthcare markets.
Investors
Venture capital, private equity and strategic investors evaluating healthcare AI opportunities.
Pharma & Biotech
Biomarker strategy, digital pathology, companion diagnostics and clinical AI applications.
Perspectives
View all insights →Thought leadership
Building an independent AI governance model for healthcare
A practical framework for evaluating, approving and monitoring AI systems inside a clinical organization.
The healthcare AI vendor landscape, categorized
How to separate meaningful clinical AI from platform repackaging when evaluating the current market.
Coming soon
The Previsum Intelligence Layer
A private AI advisor grounded in healthcare AI benchmarks, regulatory filings and clinical evidence. Purpose-built for the strategy decisions our clients face.
Preview AI featuresLet's discuss your AI challenge.
Every engagement begins with a confidential conversation. No pitch — an expert perspective on where you are and what to consider next.
Start the conversation